Abstract. Mycotoxins are secondary metabolites of moulds that which exert adverse effects in humans and animals. It is known that direct cellular toxicity is often associated with increased cellular accumulation of toxic compounds, and membrane transport may be the first fundamental stage in the development of the cytotoxicity. To elucidate the entry pathway for mycotoxins into cells, we have investigated the interactions of human and rat organic anion transporters (hOATs/ rOats) and human organic cation transporters (hOCTs) with mycotoxins using cells stably expressing hOATs / rOats / hOCTs. The mycotoxins tested were aflatoxin B1, α-zearalenol, citrinin, citrioveridine, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, penicillic acid, rubratoxin B, and zearalenone. These mycotoxins inhibited organic anion uptake mediated by hOAT1-4, and organic cation uptake mediated by hOCT1-2. By comparing the IC 50 values of mycotoxins for hOATs, it was found that hOAT1 and hOAT3 exhibited higher affinity interactions with mycotoxins than hOAT2 and hOAT4. There was no interspecies difference between humans and rats for the interactions of OATs with mycotoxins except that of OAT3 with rubratoxin B. Finally, we observed that hOAT1-4 and hOCT1-2 mediated the uptake of aflatoxin B1. In conclusion, hOATs and hOCTs interacted with various mycotoxins. Considering the localization of hOATs / rOats and hOCTs, it was suggested that these transporters were the possible entrance pathway for mycotoxins in kidney and liver, leading to the induction of adverse effects in humans and rats.
Introduction
Mycotoxins, chemicals produced by moulds, may have developed to serve as a chemical defense system against insects, microorganisms, nematodes, grazing animals, and humans (1) . Among approximately 300 known mycotoxins, some of them are capable of producing the disease "mycotoxicosis" and death in humans and animals. Although mycotoxicosis occurs more frequently in areas with a hot and humid climate, which is favorable for the growth of moulds, they can also be found in temperate zones. Exposure to mycotoxins may occur through ingestion, inhalation, and dermal contact. Massive mycotoxin contamination of food resulting in outbreaks of diseases is only a rare occurence today in developing countries. The primary concern is the longterm effects of ingesting food contaminated with low levels of mycotoxins.
From the structural point of view, mycotoxins are classified into a diverse group of organic compounds of low molecular weight, which range from a single heterocyclic ring of 50 Da to groups of irregularly arranged 6-or 8-membered rings with molecular weight greater than 500 Da. Among the toxic effects of mycotoxins, hepatic and renal insufficiencies are the most commonly described effect of acute mycotoxin poisoning. Some mycotoxins act primarily by interfering with protein synthesis after permeating the plasma membrane (2) . For the entry of these hydrophilic compounds, special membrane proteins such as transporters are required, because they cannot penetrate the lipid bilayer of the cell membrane. The secretion of numerous organic anions and cations, including endogenous metabolites, drugs, and xenobiotics, is an important physiological function of kidneys and liver (3) . In the kidneys, the process of secreting organic anions and cations through the proximal tubular cells is achieved via unidirectional transcellular transport involving the uptake of organic anions and cations into the cells from the blood across the basolateral membrane, followed by extrusion across the brush-border membrane into the tubular lumen (4) . cDNAs encoding the human organic anion transporter (hOAT) family have been successively cloned, including OAT1 to OAT4 (5, 6) . The human organic cation transporters (hOCTs) isolated thus far are OCT1 to OCT3 (7) . The roles of OATs and OCTs in the pharmacokinetics of drugs have been gradually clarified not only in the kidney, but also in other organs including the liver (8) .
Although the elucidation of the molecular mechanisms of the plasma membrane permeation of mycotoxins is important to understand the development of their cytotoxicity, studies have mainly focused on ochratoxin A so far (9 -13) . In order to elucidate the entry pathway for various mycotoxins into the cells, we have first demostrated the interactions of hOATs and hOCTs with mycotoxins using proximal tubular cells stably expressing hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 (S2 hOAT1, S2 hOAT2, S2 hOAT3, S2 hOAT4, S2 hOCT1, and S2 hOCT2). In addition, the species difference between human and rat for the interactions of OATs with mycotoxins was elucidated using S2 hOAT1/ Oat1 and S2 hOAT3 / Oat3. The mycotoxins tested in the current study are listed in Table 1 . Cell culture S2 cells were established by culturing the microdissected S2 segment derived from transgenic mice harboring the temperature-sensitive simian virus 40 large T-antigen gene as described previously (14) . S2 is the segment of the proximal tubule where hOAT1 and hOAT3 are localized (15, 16) . The establishment and characterization of S2 hOAT1, S2 hOAT2, S2 hOAT3, S2 hOAT4, S2 hOCT1, and S2 hOCT2 and S2 cells stably expressing rat Oat1 and rat Oat3 (S2 rOat1 and S2 rOat3) were reported previously (17) . These cells were grown in a humidified incubator at 33°C and under 5% CO 2 using RITC 80-7 medium containing 5% fetal bovine serum, 10 mg / ml transferrin, 0.08 U / ml insulin, 10 ng / ml recombinant epidermal growth factor, and 400 mg / ml geneticin. The cells were subcultured in a medium containing 0.05% trypsin-EDTA solution (137 mM NaCl, 5.4 mM KCl, 5.5 mM glucose, 4 mM NaHCO 3 , 0.5 mM EDTA, and 5 mM Hepes, pH 7.2) and used for 25 -35 3 H]TEA for hOCT1 and hOCT2. These compounds are recognized as prototypical transport substrates for these transporters as described previously (15, 16, 18 -22) .
Materials and Methods

Materials
Uptake experiments
Uptake experiments were performed as previously described (13) . Cells were seeded in 24-well tissue culture plates at a density of 1 × 10 5 cells / well. After the cells were cultured for two days, the cells were washed three times with Dulbecco's modified phosphatebuffered saline (137 mM NaCl, 3 mM KCl, 8 mM NaHPO 4 , 1 mM KH 2 PO 4 , 1 mM CaCl 2 , and 0.5 mM MgCl 2 , pH 7.4) supplemented with 5.5 mM glucose and then preincubated in the same solution in a water bath at 37°C for 10 min. The cells were then incubated in a solution containing 100 nM [ 3 H]aflatoxin B1 at 37°C up to 30 min. The uptake was stopped by the addition of ice-cold Dulbecco's modified phosphate-buffered saline, and the cells were washed three times with the same solution. The cells in each well were lysed with 0.5 ml of 0.1 N sodium hydroxide and 2.5 ml of aquasol-2, and radioactivity was determined by using a β-scintillation counter (LSC-3100; Aloka, Tokyo).
Inhibition study
To evaluate the inhibitory effects of mycotoxins on organic anion uptake mediated by hOAT1, hOAT2, hOAT3, hOAT4, rOat1, and rOat3 and organic cation uptake mediated by hOCT1 and hOCT2, the cells were incubated in a solution containing either [ 3 H]TEA for 5 min (hOCT1 and hOCT2) in the absence or presence of various concentrations of mycotoxins at 37°C. Dose-dependent inhibition experiments were performed at concentrations up to 1 mM, whereas the interaction of hOAT2 with aflatoxin B1 was examined at concentrations up to 2 mM. We have already confirmed that the concentrations of the compounds up to 2 mM did not have any cytotoxic effect within 1 h (data not shown). All of the mycotoxins tested were dissolved in dimethylsulfoxide and diluted with the incubation medium. The final concentration of dimethylsulfoxide in the incubation medium was adjusted to less than 0.4 %.
Statistical analysis
Data are expressed as means ± S.E.M. Statistical differences were determined using one-way ANOVA with Dunnett's post-hoc test. Differences were considered significant at P<0.05.
Results
Effects of mycotoxins on organic anion uptake mediated by hOATs
We examined the inhibitory effects of various concentrations of mycotoxins on the organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4. Figure 1 shows the effects of aflatoxin B1 on the organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4. Aflatoxin B1 significantly inhibited the organic anion uptake mediated by hOAT1 (A), hOAT2 (B), hOAT3 (C), and hOAT4 (D) in a dose-dependent manner. Similarly, other mycotoxins including α-zearalenol, citrioverdine, citrinin, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, penicillic acid, and zearalenone significantly inhibited the organic anion uptake mediated by hOAT1, hOAT2, hOAT3, and hOAT4, whereas no inhibition was observed for hOAT2 with fumonisin B1, gliotoxin, patulin, penicillic acid, and rubratoxin B, hOAT3 with rubratoxin B, and hOAT4 with rubratoxin B. The IC 50 values of aflatoxin B1, α-zearalenol, citrioveridine, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, and zearalenone for the organic anion uptake by hOATs are listed in Table 2 , and the effects of citrinin, penicillic acid, and rubratoxin B at 1 mM on the organic anion uptake by hOATs are listed in Table 3 .
Comparison of effects of mycotoxins on organic anion uptake mediated by OATs between humans and rats
In order to elucidate whether there are any interspecies differences for the interactions of OAT1 and OAT3 with mycotoxins between humans and rats, we examined the effects of various mycotoxins (1 mM) on the organic anion uptake mediated by hOAT1, hOAT3, rOat1, and rOat3. As shown in Fig. 2 , mycotoxins at 1 mM significantly inhibited the organic anion uptake mediated by rOat1 and hOAT1 (A) and rOat3 and hOAT3 (B), with the exception of the effect of rubratoxin B on hOAT3.
Effects of mycotoxins on organic cation uptake mediated by hOCTs
We also examined the effects of various concentrations of mycotoxins on the organic cation uptake mediated by hOCT1 and hOCT2. As shown in Fig. 1 , aflatoxin B1 significantly inhibited TEA uptake mediated by hOCT1 (E) and hOCT2 (F). Similarly, other mycotoxins including α-zearalenol, citrioveridine, citrinin, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, penicillic acid, rubratoxin B, and zearalenone significantly inhibited the organic cation uptake mediated by hOCT1 and hOCT2, whereas no inhibition was observed for hOCT1 with patulin, penicillic acid, and rubratoxin B and for hOCT2 with citrinin, fumonisin B1, and penicillic acid. The IC 50 values of aflatoxin B1, α-zearalenol, citrioveridine, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, and zearalenone for the organic cation uptake by hOCTs are listed in Table 2 ; and the effects of citrinin, penicillic acid, and rubratoxin B at 1 mM on the organic cation uptake by hOCTs are listed in Table 3 .
Aflatoxin B1 uptake mediated by hOATs and hOCTs
In order to determine whether hOATs and hOCTs mediate the uptake of mycotoxins, we evaluated the uptake activities of [ 3 H]aflatoxin B1, which is commercially available in Japan, by hOATs and hOCTs. The uptake rates of [ 3 H]aflatoxin B1 by hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 were significantly higher than that by mock (Fig. 3) . These results suggest that hOAT1, hOAT2, hOAT3, hOAT4, hOCT1, and hOCT2 mediate the transport of aflatoxin B1.
Discussion
The transport characteristics of OATs and OCTs and their localization have been elucidated mainly in the kidneys and liver. These transporters mainly mediate the transport of organic ions with a molecular weight <500 (3). As a consequence of the secretory roles for xenobiotics, kidneys and liver are exposed to several toxicants including small organic compounds mycotoxins (50 -500 Da). The most commonly described effects of acute mycotoxin poisoning are hepatic and renal insufficiencies, which may lead to death in extreme cases. It is known that direct cellular toxicity is often associated with increased cellular accumulation of toxic compounds. Thus, transport via OATs and OCTs may be the first fundamental stage in the development of nephro-and hapatotoxicity. To elucidate the entry pathway for mycotoxins into the cells, we have investigated the interactions of OATs and OCTs with mycotoxins using cells stably expressing hOATs / rOats / hOCTs in this study.
Mycotoxins such as aflatoxin B1, α-zearalenol, citrinin, citrioveridine, cyclopiazonic acid, fumonisin B1, gliotoxin, patulin, penicillic acid, rubratoxin B, and zearalenone (154.1 -721.8 Da) inhibited organic anion uptake mediated by hOAT1-4 and organic cation uptake mediated by hOCT1-2. These results suggest that the mycotoxins tested here are the potential transport substrates for OATs and OCTs. Using the radiolabelled aflatoxin B1, which is the only commercially available mycotoxin in Japan besides ochratoxin A, we confirmed that hOAT1-4 and hOCT1-2 mediated the uptake of aflatoxin B1. Thus, OATs and OCTs are the potential entrance pathway for mycotoxins in kidneys and liver, leading to their intracellular accumulation.
By comparing the IC 50 values of mycotoxins among hOATs, we found that hOAT1 and hOAT3 generally exhibit the highest affinity for mycotoxins, whereas hOAT2 and hOAT4 exhibit the lowest affinity for mycotoxins. This tendency was also true for the interactions of hOATs with ochratoxin A (12, 13), nonsteroidal anti-inflammatory drugs (23) , and organic anion transport inhibitors (24, 25) . Thus, the affinity rank order for the interactions of hOATs with mycotoxins may not to be specific to mycotoxins, but may be applied in general. On the other hand, comparing the IC 50 values of mycotoxins between hOCT1 and hOCT2, a significant difference (more than threefold difference) in the IC 50 values was observed for α-zearalenol, gliotoxin, and zearalenone. Applying the same criteria, a previous report suggests that hOCT1 and hOCT2 are distinct for the interactions with progesterone, β-estradiol, prazosin, and SFF550 (26) . Thus, it appears that hOCT1 and hOCT2 exhibit distinct substrate recognition properties depending on the substrate.
Aflatoxin B1 is mainly responsible for toxicity in both acute and chronic aflatoxicosis (27) . Epidemiological studies have demonstrated that aflatoxin B1 ingestion is an important risk factor for hepatocellular cancer in humans (28) . Oral administration of aflatoxin B1 at 5 mg/ kg for 9 weeks in rats resulted in 100% hepatocellular carcinomas (29) . In addition, several outbreaks of aflatoxicosis occurring in tropical countries revealed the induction of acute liver injury, which was confirmed by morphological examination (30) . hOAT2 and hOCT1 are localized at the basolateral side of liver cells (31, 32) , and the present results demonstrate that hOAT2 and hOCT1 mediate the transport of aflatoxin B1. These evidences suggest that hOAT2 and hOCT1 may contribute to the entrance for aflatoxin B1 into the liver, leading to the induction of hepatocellular carcinoma and acute hepatoxicity.
Aflatoxins have also been found in tissues of children suffering from Reye's syndrome, which is characterized by encephalopathy (33) . In this regard, we found that hOAT3 mRNA is expressed in the brain (34) , and the localization of hOAT1 in the blood-brain barrier was recently confirmed immunohistochemically (35) . In the current study, we revealed that hOAT1 and hOAT3 mediates the transport of aflatoxin B1. These evidences suggest that hOAT1 mediates the uptake of aflatoxin B1 into the brain via the blood-brain barrier and hOAT3 is involved in the toxicological action of aflatoxin B1 within the brain.
By comparing the effects of mycotoxins on the organic anion uptake mediated by OAT1 and OAT3 between humans and rats, it was revealed that there were no interspecies differences except for the interaction of OAT3 with rubratoxin B. In addition, we have already found that there is no interspecies difference in the transport property of ochratoxin A by OAT1 between humans and rats, that is, the K m values were 0.57 and 0.42 µM, respectively (10, 12) . Further studies are necessary to clarify the effects of mycotoxins in the body using animal models like rats. In this regard, the current results may provide some information for extrapolating the results of experiments using rats to humans, although the extrapolation to humans seems inaccurate because toxic effects of mycotoxins are mostly known in experimental models.
Although the toxic potential of citrinin and fumonisin B1 in humans has not yet been reported, citrinin has been shown to cause renal dysfunction such as glucosuria and proteinuria in rats (36) , and it was recently reported that chronic exposure to fumonisin B1 induces renal tubular tumor in rats (37) . Since hOAT1 / rOat1 and hOAT3 / rOat3 interact with citrinin and fumonisin B1, these transporters may contribute to the basolateral uptake of these mycotoxins into the proximal tubular cells, as a first step in the development of nephrotoxicity. However, our data indicate that in different species, different intracellular events such as metabolism may also play a pivotal role in mycotoxin-induced nephrotoxicity as compared to the transport of mycotoxins into the cell. Since there is no report on toxicological roles of citrinin and fumonisin B1 in humans, we should also consider the interspecies differences in cellular events that lead to the induction of mycotoxin-induced nephrotoxicity.
In addition to the hOAT and hOCT families, it should be elucidated whether other human transporters and human homologues of rodent transporters mediate the transport of mycotoxins. In this regard, the following results have already been presented, that is, aflatoxin B1 transport by multidrug resistance-associated proteins 1 (38) , ochratoxin A transport by organic anion transporting polypeptide (9) , and the interaction of multidrug resistance-associated proteins 2 with ochratoxin A (11) . Further studies are necessary to clarify their role as a transport pathway.
In conclusion, hOATs, rOats, and hOCTs interact with various mycotoxins. It is suggested that hOATs, rOats, and hOCTs are the potential entrance pathway for mycotoxins mainly in kidneys and liver, leading to the induction of adverse effects in humans and rats.
